Treatment of iron deficiency anemia: practical considerations

被引:19
作者
Taylor, Sophia [1 ]
Rampton, David [2 ]
机构
[1] Royal London Hosp, Barts Hlth Trust, Dept Gastroenterol, London E1 1BB, England
[2] Univ London, Barts & London Sch Med & Dent, Ctr Digest Dis, Inst Cell & Mol Sci, London, England
来源
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE | 2015年 / 125卷 / 06期
关键词
anemia; intravenous iron; iron deficiency; hypersensitivity reactions; oral iron; INFLAMMATORY-BOWEL-DISEASE; RANDOMIZED CONTROLLED-TRIAL; INTRAVENOUS IRON; ANAPHYLACTOID REACTIONS; TOLERABILITY; SUPPLEMENTS; GUIDELINES; MANAGEMENT; DIAGNOSIS; SEVERITY;
D O I
10.20452/pamw.2888
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Iron deficiency anemia is a common problem worldwide, and doctors of all specialties need to be competent in its treatment. While most patients respond well to oral iron preparations, a substantial minority have side effects that make them adhere poorly to their treatment. For oral iron-intolerant patients, those responding poorly despite good adherence, and those with severe and/or symptomatic anemia, intravenous iron is an excellent alternative. It is, however, more expensive and carries a very small but potentially life-threatening risk of severe infusion-related hypersensitivity reactions. After outlining the main features of iron metabolism, in this review we compare the indications for therapy with oral and intravenous iron, and then focus on how to maximize the efficacy and safety of the two different routes.
引用
收藏
页码:452 / 460
页数:9
相关论文
共 50 条
[1]   Nonhematological benefits of iron [J].
Agarwal, Rajiv .
AMERICAN JOURNAL OF NEPHROLOGY, 2007, 27 (06) :565-571
[2]   A Randomized controlled trial of oral versus intravenous iron in chronic kidney disease [J].
Agarwal, Rajiv ;
Rizkala, Adel R. ;
Bastani, Bahar ;
Kaskas, Marwan O. ;
Leehey, David J. ;
Besarab, Anatole .
AMERICAN JOURNAL OF NEPHROLOGY, 2006, 26 (05) :445-454
[3]   Clinical update: intravenous iron for anaemia [J].
Auerbach, Michael ;
Ballard, Harold ;
Glaspy, John .
LANCET, 2007, 369 (9572) :1502-1504
[4]   Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety [J].
Auerbach, Michael ;
Ballard, Harold .
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2010, :338-347
[5]   Clinical features and severity grading of anaphylaxis [J].
Brown, SGA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (02) :371-376
[6]   Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis [J].
Charytan, C ;
Qunibi, W ;
Bailie, GR .
NEPHRON CLINICAL PRACTICE, 2005, 100 (03) :C55-C62
[7]   On the relative safety of intravenous iron formulations: New answers, new questions [J].
Chertow, Glenn M. ;
Winkelmayer, Wolfgang C. .
AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (09) :643-644
[8]   Diagnosis and management of iron-deficiency anaemia [J].
Cook, JD .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (02) :319-332
[9]  
European Medicines Agency, 2013, EMA579491201313
[10]   FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease [J].
Evstatiev, Rayko ;
Marteau, Philippe ;
Iqbal, Tariq ;
Khalif, Igor L. ;
Stein, Juergen ;
Bokemeyer, Bernd ;
Chopey, Ivan V. ;
Gutzwiller, Florian S. ;
Riopel, Lise ;
Gasche, Christoph .
GASTROENTEROLOGY, 2011, 141 (03) :846-U558